Genetically Modified Tobacco Reducing Harmful Compounds
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current tobacco products pose a significant health risk due to their high content of harmful compounds like nicotine, TSNAs, and PAHs, which contribute to tobacco-related diseases, and existing methods to reduce these compounds often result in products with poor taste or smoking properties.
Innovation Solution
Genetically modified tobacco with reduced levels of nicotine and sterols is developed using nucleic acid molecules that inhibit key enzymes in their biosynthetic pathways, combined with aseptic processing and packaging to maintain low TSNA levels, and the use of exogenous nicotine to adjust nicotine levels, along with chemically modified tobaccos that reduce nitrate levels and microbial flora.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If conventional tobacco products are used, then nicotine and other compounds are delivered to the user, but the health risk increases due to high content of harmful compounds
Solution Approach 1:
The patent extracts and removes harmful compounds (nicotine, TSNAs, PAHs) from tobacco products through various processing methods including chemical treatment, physical separation, and biological degradation, thereby reducing health risk while maintaining product functionality
Solution Approach 2:
The patent changes the chemical and physical parameters of tobacco products by modifying composition (reducing nitrate levels, altering microbial flora), processing conditions (temperature, time), and structure to decrease harmful compound content while preserving acceptable taste and smoking properties
2Object-affected harmful factors
If methods are used to reduce harmful compounds in tobacco, then health risk decreases, but taste and smoking properties deteriorate
Solution Approach 1:
The patent applies local quality by selectively reducing specific harmful compounds (targeted removal of nicotine, TSNAs, or PAHs) while preserving other components that contribute to taste and smoking characteristics, achieving localized modification rather than uniform reduction of all substances
Solution Approach 2:
The patent uses composite materials and formulations that combine multiple ingredients and processing techniques to achieve both reduction of harmful compounds and maintenance of sensory properties, creating a composite product that balances health benefits with user experience
3Object-affected harmful factors
If tobacco products are processed to reduce harmful compounds, then health risk decreases, but production complexity increases
Solution Approach 1:
The patent applies preliminary action by implementing reduction of harmful compounds during early stages of tobacco processing (such as during curing, fermentation, or initial manufacturing steps) rather than requiring complex post-processing treatments, thereby simplifying overall production while achieving health benefits
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach results in tobacco products with significantly reduced potential to contribute to tobacco-related diseases, maintaining acceptable taste and smoking properties while minimizing carcinogenic compounds, and extending the shelf life of tobacco products with low TSNA levels.
Implementation Method 1
nucleic acid molecules that inhibit key enzymes in their biosynthetic pathways
Data Source
AI summary
Embodiments provided herein concern tobacco and tobacco products having a reduced amount of a harmful compound. More specifically, several embodiments concern approaches to modify the expression of a gene that is involved in the production of a harmful compound in tobacco, tobacco products made using these approaches and methods of determining whether the removal of said compounds using said approaches yields a tobacco and/or a tobacco product that has a reduced potential to contribute to a tobacco-related disease.